Latin American Pharmaceutical Market Outlook 2015-2025

LONDON, September 29, 2015 /PRNewswire/ --

What can be expected from the Latin American pharmaceutical market? Which areas are going to grow at the fastest rates? Visiongain's brand new report shows you potential revenues to 2025, assessing data, trends, opportunities and prospects there.

Our 140-page report provides 121 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. You will see financial results, interviews, trends, opportunities, and revenue predictions. There is much opportunity in this fast moving market.

Forecasts from 2015-2025 and other analyses show you commercial prospects
Besides revenue forecasting to 2025, our new study provides you with recent results, growth rates, and market shares. Discover qualitative analyses (including SWOT analysis) and commercial developments.

See revenue forecasts for the leading international markets
How will leading national markets perform to 2025? Our study forecasts revenues in national markets including by product class for the following countries:
• Brazil
• Mexico
• Venezuela
• Argentina
• Colombia
• Chile

Leading companies and potential for market growth
Overall revenue for the Latin American pharmaceutical market will reach $87.29 in 2018, our work forecasts. We predict strong revenue growth through to 2025. The ageing population in many of the region's largest markets will combine with increasing investment in national health care systems to drive sales to 2025.

To see a report overview please email Sara Peerun on [email protected]

Our work analyses the key companies in the market. See visiongain's analysis of 5 leading companies, including these:
• Sanofi
• EMS
• Novartis
• Pfizer
• Bayer

A company profile gives you the following information where available:
• Historical revenues from 2013 to 2014
• Discussion of a company's activities and outlook
• Brief assessment of the companies Latin American strategy

Discover capabilities, progress, and commercial prospects, helping you stay ahead.

What issues will affect the Latin American pharmaceutical industry?
Our new report discusses issues and events affecting the Latin American pharmaceutical market. You will find discussions, including qualitative analyses:
• Highly diverse region needing strong knowledge of each national market
• Quickly evolving regulatory environment
• Economic weaknesses encouraging innovation

You will see discussions of technological, commercial, and economic matters, with emphasis on the competitive landscape and business outlooks.

How the Latin American Pharmaceutical Market Outlook 2015-2025 report helps you
In summary, our 140-page report gives you the following knowledge:
• Revenue forecasts to 2025 for the Latin American pharmaceutical market - discover the industry's prospects, finding promising places for investments and revenues
• Revenue forecasts to 2025 for the leading regional markets - Brazil, Mexico, Venezuela, Argentina, Colombia, Chile
• Economic situation across the nations of Latin America - Understand the pressures faced across the region and how to achieve growth in an increasingly challenging environment
• Assessment of 5 leading companies - analysis of Latin American results and strategies
• Discussion of what stimulates and restrains companies and the market
• Prospects for established firms and those seeking to enter the market

To see a report overview please email Sara Peerun on [email protected]

You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

Visiongain's study is for everybody needing commercial analyses for the Latin American Pharmaceutical market and leading companies. You find data, trends and predictions. Please order our report now.

To see a report overview please email Sara Peerun on [email protected]

To request an exec summary of this report please email Sara Peerun at [email protected] or call Tel: +44 (0) 20 7336 6100

Or click on https://www.visiongain.com/Report/1505/Latin-American-Pharmaceutical-Market-Outlook-2015-2025

Companies Mentioned In The Report
Abbott Laboratories
Aspen Pharmaceuticals
Bago
Bayer AG
Bioceres
Biocon
Celltrion
CFR Pharmaceuticals
EMS S.A
Genfar
Germed
GlaxoSmithKline
Hospira
Janssen RA
Laboratorio Teuto Brasileiro.
Laboratorios Bernabo
Laboratorios Kendrick
LaFrancol
LeGrand
Medley
Merck AG
Novartis
Orygen
Pemex
Pfizer
Priobiomed
Roemmers
Sandoz
Sanofi S.A
Shanghai CP Goujian
Takeda

Other Organisations Mentioned In The Report
Bolivarian Alliance for the Peoples of Our America (ALBA)
Brazilian Ministry of Health
Brazilian Unified Health System
Chilean Institute of Public Health
COFEPRIS
Instituto de Seguridad y Servicios Sociales de los Trabajadoes del Estad (ISSSTE)
Instituto Mexicano del Seguro Social (IMSS)
Instituto Venezolano de los Seguros Sociales (IVSS)
Mercosur
National Drugs Agency (ANAMED)
Pan American Health Organisation
Sistema General de Seguridad Social en Salud
The Andean Community (CAN)
The Pacific Alliance
The Union of South American Nations (USAN)
Trans-Pacific Partnership
United Nations Department of Economic and Social Affairs
Venezuelan Ministry of Popular Power for Health

SOURCE Visiongain